HomeSONN • NASDAQ
add
Sonnet BioTherapeutics Holdings, Inc.
Previous close
$3.10
Day range
$1.26 - $3.23
Year range
$1.08 - $19.00
Market cap
8.92M USD
Avg Volume
727.12K
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.80M | 41.81% |
Net income | -5.58M | -78.48% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.96M | -56.36% |
Effective tax rate | -1.09% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.12M | 3,325.93% |
Total assets | 14.88M | 437.15% |
Total liabilities | 4.10M | 25.80% |
Total equity | 10.79M | — |
Shares outstanding | 7.08M | — |
Price to book | 2.04 | — |
Return on assets | -146.36% | — |
Return on capital | -315.59% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -5.58M | -78.48% |
Cash from operations | -5.69M | -79.38% |
Cash from investing | 0.00 | — |
Cash from financing | 18.72M | 8,077.09% |
Net change in cash | 13.04M | 482.86% |
Free cash flow | -11.94M | -442.77% |
About
Founded
1999
Website
Employees
9
